Stock Market & Financial Investment News

Sarepta to host conference callManagement discusses plans to submit to the FDA, a New Drug Application by year end 2014, for Eteplirsen for treatment of Duchenne Muscular Dystrophy on a conference call to be held on April 21 at 8 am. Webcast Link